Clear Street’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Clear Street’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-138,610	Closed	-$7.76K	–	1172
2023 Q3	$7.76K	Hold	138,610	–	–	﹤0.01%	590
2023 Q2	$20.4K	Sell	138,610 -12,664	-8%	-$1.31K	﹤0.01%	579
2023 Q1	$14.4K	Sell	151,274 -561,386	-79%	-$45.2K	﹤0.01%	427
2022 Q4	$71K	Buy	712,660 +5,135	+0.7%	+$262	﹤0.01%	211
2022 Q3	$62K	Buy	707,525 +28,543	+4%	+$3.18K	﹤0.01%	255
2022 Q2	$95K	Buy	678,982 +597,282	+731%	+$111K	﹤0.01%	157
2022 Q1	$19K	Buy	+81,700	New	+$21.2K	﹤0.01%	208

Clear Street's BIOSW Position: Q4 2023 in Review

Clear Street sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 138,610 shares — an estimated $7.76K sold.

Clear Street first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $95K in Q2 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Clear Street reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Clear Street sold 138,610 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $7.76K.
Clear Street first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Clear Street's BioPlus Acquisition Corp. Warrants position peaked at $95K in Q2 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Clear Street's 13F filing for Q4 2023, filed 14 Feb 2024.